Skip to content

Exelixis EXEL Accrued Expenses

Accrued Expenses at other companies

Eli Lilly logo
Eli LillyLLY
$1.36B+22.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$7.07M+60.9%
Incyte logo
IncyteINCY
$124.92M+21.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$36.05M+35.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$39.34M+17.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's accrued expenses?
Exelixis (EXEL) reported accrued expenses of $100.29M in Q1 2026.
How has Exelixis's accrued expenses changed year-over-year?
Exelixis's accrued expenses decreased by 20.1% year-over-year, from $125.55M to $100.29M.
What is the long-term trend for Exelixis's accrued expenses?
Over 5 years (2020 to 2025), Exelixis's accrued expenses has grown at a 23.0% compound annual growth rate (CAGR), from $44.45M to $125.38M.
What does accrued expenses mean?
Expenses that have been incurred but for which no invoice has been received or payment made yet.
How do you interpret accrued expenses?
Consistent growth in line with revenue is normal; unexpected spikes may indicate unrecorded operational costs or timing shifts in vendor billing.
How does accrued expenses compare across companies?
Standard across all sectors; reflects general operational scale and the efficiency of the accounts payable process.